NCT04590508: A trial that was reported late by National University of Natural Medicine
This trial has reported, although it was 101 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04590508 |
|---|---|
| Title | A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 1, 2020 |
| Completion date | Aug. 22, 2024 |
| Required reporting date | Aug. 22, 2025, midnight |
| Actual reporting date | Dec. 1, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 101 |